Navigation Links
Extended Antiviral May Benefit Kidney Transplant Patients
Date:9/17/2009

Risk of viral infection can be cut in half with 6 months of treatment, study finds

THURSDAY, Sept. 17 (HealthDay News) -- A longer period of preventive treatment after kidney transplant can help reduce the risk that the patient will become infected with a virus that can cause devastating problems, new research suggests.

Healthy people can usually fight off the virus, called cytomegalovirus, but those with kidney transplants have weakened immune systems and are more susceptible to infection, the authors of the study noted in a news release from the American Society of Nephrology.

In the comparison study, Dr. Fu Luan, of the University of Michigan in Ann Arbor, and colleagues gave kidney transplant patients either three months or six months of treatment with the antiviral drug valganciclovir. They found that those who were given the longer treatment had a rate of infection that was half that of those who received treatment for three months (12 percent vs. 24 percent).

When the researchers took into account other factors that could have played a role, they found that the longer treatment regimen lowered the risk of cytomegalovirus by nearly two-thirds.

The study also found that the longer treatment is cost-effective, although it is expensive. But the study authors contend that it's cheaper in the long run to prevent infections that could end up being very costly.

The findings appear online Sept. 17 in the Journal of the American Society of Nephrology.

More information

Learn more about kidney transplants from the U.S. National Library of Medicine.



-- Randy Dotinga



SOURCE: American Society of Nephrology, news release, Sept. 17, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Cornerstone Therapeutics Submits Regulatory Filing for Extended-Release Antitussive Product
2. FDA Approves Lamictal(R)XR(TM); An Extended-Release Once-Daily, New Generation Treatment for Epilepsy
3. Deadline Extended for Nominations for Jay and Rose Phillips Awards and Phillips Caregiver Award
4. Shires INTUNIV (Guanfacine) extended release in children with ADHD and oppositional symptoms
5. FDA Approves ACTOplus met(R) XR (pioglitazone HCl and metformin HCl extended-release) Tablets for the Treatment of Type 2 Diabetes
6. New Once-Daily RYZOLT(TM) (tramadol HCl extended-release tablets) Now Available in the U.S.
7. Neuromed Announces Exalgo(TM) (hydromorphone HCl) Extended-Release Tablets (CII) Meets Primary Efficacy Endpoint in Pivotal Phase 3 Trial
8. Johnson & Johnson to Provide Webcast Presentation of Tapentadol Extended Release (ER) Phase 3 Clinical Data Presented at World Institute of Pain 5th Annual World Congress
9. Cipher receives tentative FDA approval for extended-release tramadol capsules
10. Bioniche Warrants Expiration Date to be Extended
11. Teaching Hospitals Post-Op Gains Not Extended to Blacks
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Extended Antiviral May Benefit Kidney Transplant Patients
(Date:3/29/2017)... ... March 29, 2017 , ... An ... braces. "The rubber bands used in conjunction with my braces always rubbed against ... design a way to prevent this problem." The O.B.S. was the result of ...
(Date:3/29/2017)... ... March 29, 2017 , ... Hamlin Dental Group, multi-location dental ... offering laser dental treatments. Dental lasers are safe and effective options, and can be ... and can improve the overall quality of care. , Dr. Hamid Reza of Hamlin ...
(Date:3/29/2017)... Richmond, VA (PRWEB) , ... March 29, 2017 , ... ... of its seventh North American office location in Richmond, Virginia, located at the Riverfront ... April 11, attended by Lieutenant Governor of Virginia Ralph S. Northam and Mayor of ...
(Date:3/28/2017)... ... March 28, 2017 , ... For many women, getting birth control isn’t as easy as it ... either don’t have access to a health care facility or a pharmacy within 60 minutes ... the United States or for many who are faced with health or personal issues that ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... elected representatives in state legislatures and Congress to protect parental rights and civil ... health and safety in America. , The demonstration coincides with a press conference ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 29, 2017 FinancialBuzz.com News Commentary  ... The U.S. could see significant ... new report published by New Frontier Data, the legal cannabis market ... of cannabis legalization in the United States , ... to be a major factor that drives growth in this sector. ...
(Date:3/28/2017)... 2017 "Chemotherapy Induced Neutropenia (CIN) – Market Insights, Epidemiology ... global market trends of the Chemotherapy Induced Neutropenia for the seven ... Europe ( France , Germany ... , UK) and Japan , as well as ... the world (RoW). The Report covers the therapeutics market ...
(Date:3/28/2017)... March 28, 2017  Rosen Law Firm, a global ... class action lawsuit on behalf of purchasers of Kitov ... pursuant and/or traceable to Kitov,s initial public offering on ... the open market from November 20, 2015 through February ... lawsuit seeks to recover damages for Kitov investors under ...
Breaking Medicine Technology: